Integrated Filing — IndAS



General information about company

Scrip Code 532321
NSE Symbol ZYDUSLIFE
MSEI Symbol NOTLISTED
ISIN INE010B01027
Name of company ZYDUS LIFESCIENCES LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 19-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 08-05-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Pharmaceuticals
Start date and time of board meeting 19-05-2026   12:00:00
End date and time of board meeting 19-05-2026   14:00:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 24-03-2025
Indicate Company website link for updated RPT policy of the Company www.zyduslife.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
There has been no default.



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Unaudited Audited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 3,74,090.00 11,48,400.00
Other income 49,510.00 1,66,750.00
Total income 4,23,600.00 13,15,150.00
2 Expenses
(a) Cost of materials consumed 93,670.00 3,53,070.00
(b) Purchases of stock-in-trade 6,890.00 19,770.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (5,620.00) (15,160.00)
(d) Employee benefit expense 51,390.00 1,96,620.00
(e) Finance costs 11,550.00 48,290.00
(f) Depreciation, depletion and amortisation expense 15,090.00 56,120.00
(f) Other Expenses
1 Other expenses 93,640.00 3,24,430.00
2 Net (gain)/ loss on foreign currency transactions (64,790.00) (1,22,870.00)
Total other expenses 28,850.00 2,01,560.00
Total expenses 2,01,820.00 8,60,270.00
3 Total profit before exceptional items and tax 2,21,780.00 4,54,880.00
4 Exceptional items (10,680.00) (16,690.00)
5 Total profit before tax 2,11,100.00 4,38,190.00
6 Tax expense
7 Current tax 44,670.00 89,980.00
8 Deferred tax (5,770.00) (7,770.00)
9 Total tax expenses 38,900.00 82,210.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 1,72,200.00 3,55,980.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 1,72,200.00 3,55,980.00
17 Other comprehensive income net of taxes (1,260.00) 2,870.00
18 Total Comprehensive Income for the period 1,70,940.00 3,58,850.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 10,060.00 10,060.00
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve 23,57,110.00
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 17.11 35.38
Diluted earnings (loss) per share from continuing operations 17.11 35.38
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 17.11 35.38
Diluted earnings (loss) per share from continuing and discontinued operations 17.11 35.38
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 5,01,120.00
Capital work-in-progress 62,120.00
Investment property 0.00
Goodwill 0.00
Other intangible assets 7,270.00
Intangible assets under development 0.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 7,27,310.00
Trade receivables, non-current 0.00
Loans, non-current 4,32,990.00
Other non-current financial assets
1 Other Financial Assets 1,270.00
Total of other non-current financial assets 1,270.00
Total non-current financial assets 11,61,570.00
Deferred tax assets (net)
Other non-current assets
1 Other non-current assets 28,030.00
2 Assets for Current tax (Net) 2,670.00
Total of other non-current assets 30,700.00
Total non-current assets 17,62,780.00
2 Current assets
Inventories 2,17,780.00
Current financial asset
Current investments 4,20,500.00
Trade receivables, current 8,49,490.00
Cash and cash equivalents 32,700.00
Bank balance other than cash and cash equivalents 40,720.00
Loans, current 3,080.00
Other current financial assets
Total of other current financial assets 6,320.00
Total current financial assets 13,52,810.00
Current tax assets (net)
Other current assets
1 Other current assets 54,590.00
Total of other current assets 54,590.00
Total current assets 16,25,180.00
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 33,87,960.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 10,060.00
Other equity 23,57,110.00
Total equity attributable to owners of parent 23,67,170.00
Non controlling interest
Total equity 23,67,170.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 4,23,290.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Lease liabilities 1,030.00
2 Other financial liabilities 3,200.00
Total of other non-current financial liabilities 4,230.00
Total non-current financial liabilities 4,27,520.00
Provisions, non-current 26,010.00
Deferred tax liabilities (net) 8,000.00
Deferred government grants, Non-current 0.00
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 4,61,530.00
Current liabilities
Current financial liabilities
Borrowings, current 3,19,820.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 8,700.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 1,38,550.00
Total Trade payable 1,47,250.00
Other current financial liabilities
1 Lease liabilities 90.00
2 Other financial liabilities 40,980.00
Total of other current financial liabilities 41,070.00
Total current financial liabilities 5,08,140.00
Other current liabilities 18,530.00
1 Other current liabilities 18,530.00
Total of other current liabilities 18,530.00
Provisions, current 13,560.00
Current tax liabilities (Net) 19,030.00
Deferred government grants, Current 0.00
Total current liabilities 5,59,260.00
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 10,20,790.00
Total equity and liabilites 33,87,960.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Unaudited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Unaudited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2 Income tax relating to items that will not be reclassified to profit or loss (180.00) (4,080.00)
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 1,440.00 1,210.00
5 Total Other comprehensive income (1,260.00) 2,870.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 4,38,190.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 48,030.00
Adjustments for decrease (increase) in inventories (22,570.00)
Adjustments for decrease (increase) in trade receivables, current 16,770.00
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 6,810.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 19,270.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (1,910.00)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 56,120.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 4,440.00
Adjustments for provisions, non-current (6,160.00)
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (91,350.00)
Adjustments for dividend income 1,10,440.00
Adjustments for interest income 46,620.00
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) (390.00)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow (270.00)
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 18,100.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (1,10,170.00)
Net cash flows from (used in) operations 3,28,020.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 1,04,590.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 2,23,430.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 21,330.00
Cash flows used in obtaining control of subsidiaries or other businesses 40,840.00
Other cash receipts from sales of equity or debt instruments of other entities 11,200.00
Other cash payments to acquire equity or debt instruments of other entities 1,090.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 1,560.00
Purchase of property, plant and equipment 89,900.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 49,110.00
Cash receipts from repayment of advances and loans made to other parties 74,950.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 1,10,440.00
Interest received 50,710.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (32,290.00)
Net cash flows from (used in) investing activities 56,960.00
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 3,23,400.00
Repayments of borrowings 4,17,750.00
Payments of lease liabilities 180.00
Dividends paid 1,10,620.00
Interest paid 52,840.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (2,57,990.00)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 22,400.00
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 22,400.00
Cash and cash equivalents cash flow statement at beginning of period 10,300.00
Cash and cash equivalents cash flow statement at end of period 32,700.00





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Deloitte Haskins & Sells LLP Yes 31-07-2027


Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Zydus Lifesciences Limited Zydus Wellness Products Limited Subsidiary Company Purchase of goods or services 12.50 Amount as approved by the Audit Committee. 12.50 0.00 0.00
2 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Purchase of goods or services 10,772.50 Amount as approved by the Audit Committee. 10,772.50 0.00 0.00
3 Zydus Lifesciences Limited Zydus VTEC Limited Subsidiary Company Sale of goods or services 36.30 Amount as approved by the Audit Committee. 36.30 0.00 0.00
4 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Purchase of goods or services 833.70 Amount as approved by the Audit Committee. 833.70 0.00 0.00
5 Zydus Lifesciences Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Purchase of goods or services 31.00 Amount as approved by the Audit Committee. 31.00 0.00 0.00
6 Zydus Lifesciences Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Purchase of goods or services 31.60 Amount as approved by the Audit Committee. 31.60 0.00 0.00
7 Zydus Lifesciences Limited Zydus Healthcare (USA) LLC Subsidiary Company Purchase of goods or services 370.90 Amount as approved by the Audit Committee. 370.90 0.00 0.00
8 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Purchase of goods or services 121.50 Amount as approved by the Audit Committee. 121.50 0.00 0.00
9 Zydus Lifesciences Limited Zydus Hospira Oncology Private Limited Joint Ventures Purchase of goods or services 17.80 Amount as approved by the Audit Committee. 17.80 0.00 0.00
10 Zydus Lifesciences Limited Sterling Biotech Limited Joint Ventures Purchase of goods or services 175.40 Amount as approved by the Audit Committee. 175.40 0.00 0.00
11 Zydus Lifesciences Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 31.90 Amount as approved by the Audit Committee. 31.90 0.00 0.00
12 Zydus Lifesciences Limited Oneiro Chemicals Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 2,927.90 Amount as approved by the Audit Committee. 2,927.90 0.00 0.00
13 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Investment 0.00 N.A. 6,332.80 0.00 0.00
14 Zydus Lifesciences Limited Zydus VTEC Limited Subsidiary Company Purchase of fixed assets 74.50 Amount as approved by the Audit Committee. 74.50 0.00 0.00
15 Zydus Lifesciences Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of fixed assets 21.50 Amount as approved by the Audit Committee. 21.50 0.00 0.00
16 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Purchase of goods or services 17.00 Amount as approved by the Audit Committee. 17.00 0.00 0.00
17 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Purchase of goods or services 4,919.30 Amount as approved by the Audit Committee. 4,919.30 0.00 0.00
18 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Purchase of goods or services 369.40 Amount as approved by the Audit Committee. 369.40 0.00 0.00
19 Zydus Lifesciences Limited Zydus Medtech France SAS Subsidiary Company Sale of goods or services 1,129.90 Amount as approved by the Audit Committee. 1,129.90 0.00 0.00
20 Zydus Lifesciences Limited Zydus Medtech France SAS Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 301.70 1,468.70
21 Zydus Lifesciences Limited LM Manufacturing Limited Subsidiary Company Purchase of goods or services 179.20 Amount as approved by the Audit Committee. 179.20 0.00 0.00
22 Zydus Lifesciences Limited LM Manufacturing Limited Subsidiary Company Purchase of goods or services 17.90 Amount as approved by the Audit Committee. 17.90 0.00 0.00
23 Zydus Lifesciences Limited LM Manufacturing Limited Subsidiary Company Sale of goods or services 60.20 Amount as approved by the Audit Committee. 60.20 0.00 0.00
24 Zydus Lifesciences Limited LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 203.40
25 Zydus Lifesciences Limited LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 63.50
26 Zydus Lifesciences Limited Vitely Corp Pvt Ltd (Formerly Known Vitely Bio LLP) Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 73.20 Amount as approved by the Audit Committee. 73.20 0.00 0.00
27 Zydus Lifesciences Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 2.50 Amount as approved by the Audit Committee. 2.50 0.00 0.00
28 Zydus Lifesciences Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 21.00 Amount as approved by the Audit Committee. 21.00 0.00 0.00
29 Zydus Lifesciences Limited Mukesh M. Patel & Co., Proprietorship Firm Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 50.00 Amount as approved by the Audit Committee. 50.00 0.00 0.00
30 Zydus Lifesciences Limited International Tax & Investment Consultants-Proprietorship Firm Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 33.30 Amount as approved by the Audit Committee. 33.30 0.00 0.00
31 Zydus Lifesciences Limited TUV India Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.50 Amount as approved by the Audit Committee. 0.50 0.00 0.00
32 Zydus Lifesciences Limited Apollo Healthco Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 3.90 2.20
33 Zydus Lifesciences Limited Apollo Healthco Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 40.50 Amount as approved by the Audit Committee. 40.50 0.00 0.00
34 Zydus Lifesciences Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 329.00 Amount as approved by the Audit Committee. 329.00 0.00 0.00
35 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Reimbursement of Expenses paid 10,474.20 Amount as approved by the Audit Committee. 10,474.20 0.00 0.00
36 Zydus Lifesciences Limited Zydus Healthcare (USA) LLC Subsidiary Company Any other transaction Reimbursement of Expenses paid 399.80 Amount as approved by the Audit Committee. 399.80 0.00 0.00
37 Zydus Lifesciences Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Any other transaction Reimbursement of Expenses paid 426.80 Amount as approved by the Audit Committee. 426.80 0.00 0.00
38 Zydus Lifesciences Limited Zydus Pharmaceuticals Mexico SA De CV Subsidiary Company Any other transaction Reimbursement of Expenses paid 96.50 Amount as approved by the Audit Committee. 96.50 0.00 0.00
39 Zydus Lifesciences Limited Zydus France, SAS Subsidiary Company Any other transaction Reimbursement of Expenses paid 916.20 Amount as approved by the Audit Committee. 916.20 0.00 0.00
40 Zydus Lifesciences Limited Laboratorios Combix S.L. Subsidiary Company Any other transaction Reimbursement of Expenses paid 1,982.10 Amount as approved by the Audit Committee. 1,982.10 0.00 0.00
41 Zydus Lifesciences Limited Zydus Lanka (Private) Limited Subsidiary Company Any other transaction Reimbursement of Expenses paid 3.30 Amount as approved by the Audit Committee. 3.30 0.00 0.00
42 Zydus Lifesciences Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Any other transaction Reimbursement of Expenses paid 35.30 Amount as approved by the Audit Committee. 35.30 0.00 0.00
43 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 9.50 Amount as approved by the Audit Committee. 9.50 0.00 0.00
44 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Loan 0.00 N.A. 14,810.00 0.00 0.00 Loan 0.800 5 Year Unsecured Business Purpose Textual Information(1)
45 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Interest received 0.00 N.A. 167.60 0.00 0.00
46 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 0.00 14,960.80
47 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Any other transaction Reimbursement of Expenses paid 859.70 Amount as approved by the Audit Committee. 859.70 0.00 0.00
48 Zydus Lifesciences Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Reimbursement of Expenses paid 0.50 Amount as approved by the Audit Committee. 0.50 0.00 0.00
49 Zydus Lifesciences Limited Zydus Hospira Oncology Private Limited Joint Ventures Any other transaction Reimbursement of Expenses paid 13.20 Amount as approved by the Audit Committee. 13.20 0.00 0.00
50 Zydus Lifesciences Limited Zydus Hospira Oncology Private Limited Joint Ventures Any other transaction Reimbursement of Expenses Recovered 92.20 Amount as approved by the Audit Committee. 92.20 0.00 0.00
51 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Sale of goods or services 7.50 Amount as approved by the Audit Committee. 7.50 0.00 0.00
52 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Sale of goods or services 11,168.40 Amount as approved by the Audit Committee. 11,168.40 0.00 0.00
53 Zydus Lifesciences Limited Zydus VTEC Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 1.20 Amount as approved by the Audit Committee. 1.20 0.00 0.00
54 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Sale of goods or services 5,094.50 Amount as approved by the Audit Committee. 5,094.50 0.00 0.00
55 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Sale of goods or services 2,94,843.00 Amount as approved by the Audit Committee. 2,94,843.00 0.00 0.00
56 Zydus Lifesciences Limited Viona Pharmaceuticals INC Subsidiary Company Sale of goods or services 17,861.30 Amount as approved by the Audit Committee. 17,861.30 0.00 0.00
57 Zydus Lifesciences Limited Zydus Healthcare Philippines Inc. Subsidiary Company Sale of goods or services 2,885.40 Amount as approved by the Audit Committee. 2,885.40 0.00 0.00
58 Zydus Lifesciences Limited Alidac Healthcare (Myanmar) Limited Subsidiary Company Sale of goods or services 1,350.90 Amount as approved by the Audit Committee. 1,350.90 0.00 0.00
59 Zydus Lifesciences Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Sale of goods or services 4,205.70 Amount as approved by the Audit Committee. 4,205.70 0.00 0.00
60 Zydus Lifesciences Limited Zydus Pharmaceuticals Mexico SA De CV Subsidiary Company Sale of goods or services 8,760.90 Amount as approved by the Audit Committee. 8,760.90 0.00 0.00
61 Zydus Lifesciences Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Sale of goods or services 7,581.10 Amount as approved by the Audit Committee. 7,581.10 0.00 0.00
62 Zydus Lifesciences Limited Zydus France, SAS Subsidiary Company Sale of goods or services 4,486.10 Amount as approved by the Audit Committee. 4,486.10 0.00 0.00
63 Zydus Lifesciences Limited Laboratorios Combix S.L. Subsidiary Company Sale of goods or services 2,897.10 Amount as approved by the Audit Committee. 2,897.10 0.00 0.00
64 Zydus Lifesciences Limited Zydus Worldwide DMCC Subsidiary Company Sale of goods or services 2,105.80 Amount as approved by the Audit Committee. 2,105.80 0.00 0.00
65 Zydus Lifesciences Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Sale of goods or services 13,679.60 Amount as approved by the Audit Committee. 13,679.60 0.00 0.00
66 Zydus Lifesciences Limited Zydus Takeda Healthcare Private Limited Joint Ventures Sale of goods or services 682.10 Amount as approved by the Audit Committee. 682.10 0.00 0.00
67 Zydus Lifesciences Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Sale of goods or services 141.40 Amount as approved by the Audit Committee. 141.40 0.00 0.00
68 Zydus Lifesciences Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Sale of goods or services 8.30 Amount as approved by the Audit Committee. 8.30 0.00 0.00
69 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 4.20 Amount as approved by the Audit Committee. 4.20 0.00 0.00
70 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Loan 0.00 N.A. 6,000.00 0.00 0.00
71 Zydus Lifesciences Limited Alidac Healthcare (Myanmar) Limited Subsidiary Company Purchase of goods or services 18.10 Amount as approved by the Audit Committee. 18.10 0.00 0.00
72 Zydus Lifesciences Limited Alidac Healthcare (Myanmar) Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 18.70
73 Zydus Lifesciences Limited Alidac Healthcare (Myanmar) Limited Subsidiary Company Sale of goods or services 150.10 Amount as approved by the Audit Committee. 150.10 0.00 0.00
74 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Purchase of fixed assets 7.60 Amount as approved by the Audit Committee. 7.60 0.00 0.00
75 Zydus Lifesciences Limited Zydus Wellness Limited Subsidiary Company Sale of goods or services 47.40 Amount as approved by the Audit Committee. 47.40 0.00 0.00
76 Zydus Lifesciences Limited Zydus Wellness Products Limited Subsidiary Company Sale of goods or services 121.40 Amount as approved by the Audit Committee. 121.40 0.00 0.00
77 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Sale of goods or services 45.30 Amount as approved by the Audit Committee. 45.30 0.00 0.00
78 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Sale of goods or services 61.30 Amount as approved by the Audit Committee. 61.30 0.00 0.00
79 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Sale of goods or services 20.60 Amount as approved by the Audit Committee. 20.60 0.00 0.00
80 Zydus Lifesciences Limited Zydus VTEC Limited Subsidiary Company Sale of goods or services 175.50 Amount as approved by the Audit Committee. 175.50 0.00 0.00
81 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Sale of goods or services 4,404.30 Amount as approved by the Audit Committee. 4,404.30 0.00 0.00
82 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Sale of goods or services 193.80 Amount as approved by the Audit Committee. 193.80 0.00 0.00
83 Zydus Lifesciences Limited Sentynl Therapeutics Inc. Subsidiary Company Sale of goods or services 142.60 Amount as approved by the Audit Committee. 142.60 0.00 0.00
84 Zydus Lifesciences Limited Viona Pharmaceuticals INC Subsidiary Company Sale of goods or services 69.00 Amount as approved by the Audit Committee. 69.00 0.00 0.00
85 Zydus Lifesciences Limited Zydus Therapeutics INC Subsidiary Company Sale of goods or services 399.60 Amount as approved by the Audit Committee. 399.60 0.00 0.00
86 Zydus Lifesciences Limited Zydus Worldwide DMCC Subsidiary Company Sale of goods or services 56.30 Amount as approved by the Audit Committee. 56.30 0.00 0.00
87 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Sale of goods or services 278.50 Amount as approved by the Audit Committee. 278.50 0.00 0.00
88 Zydus Lifesciences Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Sale of goods or services 1,218.70 Amount as approved by the Audit Committee. 1,218.70 0.00 0.00
89 Zydus Lifesciences Limited Zydus Medtech Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 12.70
90 Zydus Lifesciences Limited Zydus Medtech Private Limited Subsidiary Company Investment 0.00 N.A. 0.00 16,050.00 0.00
91 Zydus Lifesciences Limited Zydus Medtech Private Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 2.40 Amount as approved by the Audit Committee. 2.40 0.00 0.00
92 Zydus Lifesciences Limited Zydus Medtech Private Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 22.00 0.00
93 Zydus Lifesciences Limited Zydus Medtech Private Limited Subsidiary Company Sale of goods or services 11.20 Amount as approved by the Audit Committee. 11.20 0.00 0.00
94 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 641.00 Amount as approved by the Audit Committee. 641.00 0.00 0.00
95 Zydus Lifesciences Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Interest received 0.00 N.A. 1,043.20 0.00 0.00
96 Zydus Lifesciences Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 32,144.50 34,232.10
97 Zydus Lifesciences Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 1,452.80 Amount as approved by the Audit Committee. 1,452.80 0.00 0.00
98 Zydus Lifesciences Limited Zydus Wellness Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 7.40 Amount as approved by the Audit Committee. 7.40 0.00 0.00
99 Zydus Lifesciences Limited Zydus Wellness Products Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 7.40 Amount as approved by the Audit Committee. 7.40 0.00 0.00
100 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 216.30 Amount as approved by the Audit Committee. 216.30 0.00 0.00
101 Zydus Lifesciences Limited Mr. Pankaj R. Patel Key Managerial Personnel Any other transaction Director Sitting Fees 0.00 N.A. 3.00 0.00 0.00
102 Zydus Lifesciences Limited Dr. Sharvil P. Patel Key Managerial Personnel Remuneration 0.00 N.A. 2,700.00 0.00 0.00
103 Zydus Lifesciences Limited Mr. Ganesh N. Nayak Key Managerial Personnel Remuneration 0.00 N.A. 179.90 0.00 0.00
104 Zydus Lifesciences Limited Mr. Tushar D. Shroff Key Managerial Personnel Remuneration 0.00 N.A. 188.40 0.00 0.00
105 Zydus Lifesciences Limited Mr. Dhaval N. Soni Key Managerial Personnel Remuneration 0.00 N.A. 30.40 0.00 0.00
106 Zydus Lifesciences Limited Dialforhealth Unity Limited Subsidiary Company Interest received 0.00 N.A. 1.00 0.00 0.00
107 Zydus Lifesciences Limited Zydus International Private Limited Subsidiary Company Interest received 0.00 N.A. 2,853.00 0.00 0.00
108 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Interest received 0.00 N.A. 2,222.00 0.00 0.00
109 Zydus Lifesciences Limited Sentynl Therapeutics Inc. Subsidiary Company Interest received 0.00 N.A. 3,080.20 0.00 0.00
110 Zydus Lifesciences Limited Zydus Worldwide DMCC Subsidiary Company Interest received 0.00 N.A. 552.10 0.00 0.00
111 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Sale of goods or services 212.20 Amount as approved by the Audit Committee. 212.20 0.00 0.00
112 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Interest received 0.00 N.A. 512.00 0.00 0.00
113 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Interest paid 0.00 N.A. 323.80 0.00 0.00
114 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Interest paid 0.00 N.A. 2,964.30 0.00 0.00
115 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Interest paid 0.00 N.A. 12,388.40 0.00 0.00
116 Zydus Lifesciences Limited Zydus Takeda Healthcare Private Limited Joint Ventures Dividend received 0.00 N.A. 3,500.00 0.00 0.00
117 Zydus Lifesciences Limited Zydus International Private Limited Subsidiary Company Loan 0.00 N.A. 7,474.20 0.00 0.00
118 Zydus Lifesciences Limited LM Manufacturing India Private Limited Subsidiary Company Loan 0.00 N.A. 43.50 0.00 0.00
119 Zydus Lifesciences Limited LM Manufacturing India Private Limited Subsidiary Company Interest received 0.00 N.A. 1.10 0.00 0.00
120 Zydus Lifesciences Limited LM Manufacturing India Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 44.90 0.00
121 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Investment 0.00 N.A. 500.00 98,500.00 99,000.00 Investment 0 N.A Unsecured Business Purpose Textual Information(2)
122 Zydus Lifesciences Limited Zydus Pharmaceuticals Canada Inc. Subsidiary Company Any other transaction Reimbursement of Expenses paid 1,367.40 Amount as approved by the Audit Committee. 1,367.40 0.00 0.00
123 Zydus Lifesciences Limited Zydus Pharmaceuticals Canada Inc. Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 112.10 Amount as approved by the Audit Committee. 112.10 0.00 0.00
124 Zydus Lifesciences Limited Zydus Pharmaceuticals Canada Inc. Subsidiary Company Sale of goods or services 84.10 Amount as approved by the Audit Committee. 84.10 0.00 0.00
125 Zydus Lifesciences Limited Zydus Pharmaceuticals Canada Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 201.10
126 Zydus Lifesciences Limited Zydus Pharmaceuticals Canada Inc. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 11.70 279.90
127 Zydus Lifesciences Limited Zynext Ventures Pte. Ltd. Subsidiary Company Investment 0.00 N.A. 13,525.70 0.00 13,525.70 Investment 0 N.A Unsecured Business Purpose Textual Information(3)
128 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Loan 0.00 N.A. 8,836.90 0.00 0.00
129 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Investment 0.00 N.A. 15,000.00 0.00 0.00
130 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Loan 0.00 N.A. 90,628.90 0.00 0.00
131 Zydus Lifesciences Limited Zydus Worldwide DMCC Subsidiary Company Loan 0.00 N.A. 3,843.50 0.00 0.00
132 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Loan 0.00 N.A. 65,053.20 0.00 0.00
133 Zydus Lifesciences Limited Cadila Healthcare Ltd. Managerial Cadre EPF Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 0.00 N.A. 2,374.30 0.00 0.00
134 Zydus Lifesciences Limited Cadila Healthcare Limited Employees Group Gratuity Scheme Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 0.00 N.A. 12,500.00 0.00 0.00
135 Zydus Lifesciences Limited Zylidac Bio LLC, USA Subsidiary Company Purchase of goods or services 5,158.10 Amount as approved by the Audit Committee. 5,158.10 0.00 0.00
136 Zydus Lifesciences Limited Zylidac Bio LLC, USA Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 5,158.10
137 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 1,17,775.80 90,766.30
138 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 3,92,795.50 3,92,441.70
139 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 10,001.70 4,119.40
140 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 2,578.80 5,890.40
141 Zydus Lifesciences Limited Zydus VTEC Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 289.00 170.70
142 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 2,436.50 0.00
143 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 9,111.00 6,397.70
144 Zydus Lifesciences Limited Zydus Healthcare (USA) LLC Subsidiary Company Investment 0.00 N.A. 0.00 2,206.80 0.00
145 Zydus Lifesciences Limited Zydus Healthcare (USA) LLC Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 411.20 626.60
146 Zydus Lifesciences Limited Viona Pharmaceuticals INC Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 838.70 895.90
147 Zydus Lifesciences Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Sale of goods or services 32.70 Amount as approved by the Audit Committee. 32.70 0.00 0.00
148 Zydus Lifesciences Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 3,113.20 3,791.20
149 Zydus Lifesciences Limited Zydus Pharmaceuticals Mexico SA De CV Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 685.40 834.90
150 Zydus Lifesciences Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 876.50 982.10
151 Zydus Lifesciences Limited Zydus France, SAS Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 3,178.60 3,187.60
152 Zydus Lifesciences Limited Zydus Lanka (Private) Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 4.80 3.00
153 Zydus Lifesciences Limited Zydus Lanka (Private) Limited Subsidiary Company Sale of goods or services 63.40 Amount as approved by the Audit Committee. 63.40 0.00 0.00
154 Zydus Lifesciences Limited Zydus Lanka (Private) Limited Subsidiary Company Sale of goods or services 22.20 Amount as approved by the Audit Committee. 22.20 0.00 0.00
155 Zydus Lifesciences Limited Zydus Lanka (Private) Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 48.40 88.20
156 Zydus Lifesciences Limited Zydus Wellness Products Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 132.00 10.40
157 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 651.50 1,043.20
158 Zydus Lifesciences Limited Sterling Biotech Limited Joint Ventures Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 135.50 145.30
159 Zydus Lifesciences Limited Zydus Hospira Oncology Private Limited Joint Ventures Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 24.70
160 Zydus Lifesciences Limited Zydus Hospira Oncology Private Limited Joint Ventures Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 3.00 0.00
161 Zydus Lifesciences Limited Vitely Corp Pvt Ltd (Formerly Known Vitely Bio LLP) Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 37.80 9.80
162 Zydus Lifesciences Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.90 1.20
163 Zydus Lifesciences Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 26.00 32.70
164 Zydus Lifesciences Limited Oneiro Chemicals Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 1,734.60 662.90
165 Zydus Lifesciences Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 621.40 275.20
166 Zydus Lifesciences Limited Aleta Hospitals LLP [Formerly known as Zydus Hospitals (Vadodara) LLP] Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 0.00
167 Zydus Lifesciences Limited Dr. Sharvil P. Patel Key Managerial Personnel Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 2,711.30 2,707.50
168 Zydus Lifesciences Limited Dialforhealth Unity Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 26.60 27.50
169 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 24,530.80 15,921.00
170 Zydus Lifesciences Limited Zydus International Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 1,30,757.30 1,29,474.70
171 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 97,647.00 1,04,280.00
172 Zydus Lifesciences Limited Sentynl Therapeutics Inc. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 1,06,524.00 1,13,760.00
173 Zydus Lifesciences Limited Zydus Worldwide DMCC Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 25,451.10 23,416.10
174 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 3,852.00
175 Zydus Lifesciences Limited Zydus Wellness Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 43.50 50.30
176 Zydus Lifesciences Limited Zydus Wellness Products Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 132.40 140.00
177 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 75.50 124.00
178 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 199.90 264.40
179 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 36.40 96.00
180 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 6,077.00 13,141.50
181 Zydus Lifesciences Limited Zydus VTEC Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 137.00 39.20
182 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 5,95,956.20 5,90,904.80
183 Zydus Lifesciences Limited Sentynl Therapeutics Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 159.10 149.60
184 Zydus Lifesciences Limited Viona Pharmaceuticals INC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 22,845.40 15,953.70
185 Zydus Lifesciences Limited Zydus Therapeutics INC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 552.30 205.20
186 Zydus Lifesciences Limited Zydus Healthcare Philippines Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 4,989.70 2,370.50
187 Zydus Lifesciences Limited Alidac Healthcare (Myanmar) Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 3,156.50 987.40
188 Zydus Lifesciences Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 13,335.00 14,521.50
189 Zydus Lifesciences Limited Zydus Pharmaceuticals Mexico SA De CV Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 16,375.50 17,736.50
190 Zydus Lifesciences Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 22,527.30 11,716.60
191 Zydus Lifesciences Limited Zydus France, SAS Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 13,771.10 17,612.90
192 Zydus Lifesciences Limited Etna Biotech S.R.L. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 1,025.90 1,070.50
193 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 685.10 288.80
194 Zydus Lifesciences Limited Laboratorios Combix S.L. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 4,735.90 4,313.10
195 Zydus Lifesciences Limited Laboratorios Combix S.L. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 515.80
196 Zydus Lifesciences Limited Zydus Worldwide DMCC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 2,398.20 656.50
197 Zydus Lifesciences Limited Zydus Takeda Healthcare Private Limited Joint Ventures Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 737.20 804.90
198 Zydus Lifesciences Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 70.20 87.50
199 Zydus Healthcare Limited Oneiro Chemicals Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 11.90 Amount as approved by the Audit Committee. 11.90 0.00 0.00
200 Zydus Healthcare Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Purchase of goods or services (1.60) Amount as approved by the Audit Committee. (1.60) 0.00 0.00
201 Zydus Healthcare Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 1.20 Amount as approved by the Audit Committee. 1.20 0.00 0.00
202 Zydus Healthcare Limited German Remedies Pharma Private Limited Subsidiary Company Purchase of fixed assets 1.20 Amount as approved by the Audit Committee. 1.20 0.00 0.00
203 Zydus Healthcare Limited Zydus Hospira Oncology Private Limited Joint Ventures Purchase of goods or services 55.20 Amount as approved by the Audit Committee. 55.20 0.00 0.00
204 Zydus Healthcare Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 1.70 Amount as approved by the Audit Committee. 1.70 0.00 0.00
205 Zydus Healthcare Limited Mukesh M. Patel & Co., Proprietorship Firm Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 12.00 Amount as approved by the Audit Committee. 12.00 0.00 0.00
206 Zydus Healthcare Limited German Remedies Pharma Private Limited Subsidiary Company Sale of goods or services 575.70 Amount as approved by the Audit Committee. 575.70 0.00 0.00
207 Zydus Healthcare Limited Apollo Healthco Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 1,500.50 Amount as approved by the Audit Committee. 1,500.50 0.00 0.00
208 Zydus Healthcare Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Sale of goods or services 199.40 Amount as approved by the Audit Committee. 199.40 0.00 0.00
209 Zydus Healthcare Limited Ramanbhai Foundation Enterprises significantly influenced by Directors and/ or their relatives Sale of goods or services 9.00 Amount as approved by the Audit Committee. 9.00 0.00 0.00
210 Zydus Healthcare Limited Zydus Wellness Products Limited Subsidiary Company Sale of goods or services 116.50 Amount as approved by the Audit Committee. 116.50 0.00 0.00
211 Zydus Healthcare Limited Dr. Sharvil P. Patel Key Managerial Personnel Any other transaction Director Sitting Fees 0.00 N.A. 3.00 0.00 0.00
212 Zydus Healthcare Limited Zydus Foundation Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Corporate Social Responsibility (CSR) Expenses 0.00 N.A. 330.00 0.00 0.00
213 Zydus Healthcare Limited Sterling Biotech Limited Joint Ventures Purchase of goods or services 15.50 Amount as approved by the Audit Committee. 15.50 0.00 0.00
214 Zydus Healthcare Limited Sterling Biotech Limited Joint Ventures Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 15.50 16.30
215 Zydus Healthcare Limited Zydus Animal Health and Investments Limited Subsidiary Company Purchase of goods or services 69.80 Amount as approved by the Audit Committee. 69.80 0.00 0.00
216 Zydus Healthcare Limited Zydus Animal Health and Investments Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 5.80
217 Zydus Healthcare Limited Zydus Foundation Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 1.30 1.30
218 Zydus Healthcare Limited Zydus Lifesciences Limited Parent Company Loan 0.00 N.A. 9,254.00 0.00 0.00 Loan 0.900 5 Year Unsecured Business Purpose Textual Information(4)
219 Zydus Healthcare Limited Zydus Lifesciences Limited Parent Company Loan 0.00 N.A. 50,000.00 0.00 0.00 Loan 0.800 5 Year Unsecured Business Purpose Textual Information(5)
220 Zydus Healthcare Limited Zydus Lifesciences Limited Parent Company Loan 0.00 N.A. 30,700.00 0.00 0.00 Loan 0.9500 5 Year Unsecured Business Purpose Textual Information(6)
221 Zydus Healthcare Limited Recon Pharmaceuticals and Investments Subsidiary Company Any other transaction Share of profit Received 0.00 N.A. 0.90 0.00 0.00
222 Zydus Healthcare Limited Zydus Healthcare Limited Employees Group Gratuity Scheme Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 0.00 N.A. 2,500.00 0.00 0.00
223 Zydus Healthcare Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.70 0.80
224 Zydus Healthcare Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 12.00 9.20
225 Zydus Healthcare Limited Oneiro Chemicals Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 7.50
226 Zydus Healthcare Limited Mr. Tushar D. Shroff Key Managerial Personnel Any other transaction Director Sitting Fees 0.00 N.A. 4.00 0.00 0.00
227 Zydus Healthcare Limited Zydus Pharmaceuticals Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 2.50
228 Zydus Healthcare Limited Zydus Medtech Private Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 20.70
229 Zydus Healthcare Limited Ramanbhai Foundation Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 2.00 2.80
230 Zydus Healthcare Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 63.70 67.90
231 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Purchase of goods or services 588.20 Amount as approved by the Audit Committee. 588.20 0.00 0.00
232 Zydus Wellness Limited Alidac UK Limited Subsidiary Company Loan 0.00 N.A. 2,458.50 0.00 0.00 Loan 2.1500 2 Year Unsecured Business Purpose Textual Information(7)
233 Zydus Wellness Limited Alidac UK Limited Subsidiary Company Interest received 0.00 N.A. 13.00 0.00 0.00
234 Zydus Wellness Limited Alidac UK Limited Subsidiary Company Investment 0.00 N.A. 0.10 0.00 0.10 Investment 0 N.A Unsecured Business Purpose Textual Information(8)
235 Zydus Wellness Limited Alidac UK Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 381.80
236 Zydus Wellness Limited Alidac UK Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 0.00 2,512.60
237 Zydus Wellness Limited Alidac UK Limited Subsidiary Company Sale of goods or services 768.50 Amount as approved by the Audit Committee. 768.50 0.00 0.00
238 Zydus Wellness Limited Mukesh M. Patel & Co., Proprietorship Firm Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 7.80 Amount as approved by the Audit Committee. 7.80 0.00 0.00
239 Zydus Wellness Limited Zydus Healthcare Limited Subsidiary Company Purchase of goods or services 16.80 Amount as approved by the Audit Committee. 16.80 0.00 0.00
240 Zydus Wellness Limited Zydus Foundation Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Corporate Social Responsibility (CSR) Expenses 0.00 N.A. 87.20 0.00 0.00
241 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Sale of goods or services 24,948.70 Amount as approved by the Audit Committee. 24,948.70 0.00 0.00
242 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Sale of goods or services 216.60 Amount as approved by the Audit Committee. 216.60 0.00 0.00
243 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Sale of goods or services 2,231.00 Amount as approved by the Audit Committee. 2,231.00 0.00 0.00
244 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Interest paid 0.00 N.A. 465.30 0.00 0.00
245 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Loan 0.00 N.A. 4,250.00 0.00 0.00
246 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Loan 0.00 N.A. 2,500.00 0.00 0.00
247 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 65.10 Amount as approved by the Audit Committee. 65.10 0.00 0.00
248 Zydus Wellness Limited Dr. Sharvil P. Patel Key Managerial Personnel Any other transaction Director Sitting Fees 0.00 N.A. 3.00 0.00 0.00
249 Zydus Wellness Limited Mr. Ganesh N. Nayak Key Managerial Personnel Any other transaction Director Sitting Fees 0.00 N.A. 11.00 0.00 0.00
250 Zydus Wellness Limited Mr. Tarun Arora Key Managerial Personnel Remuneration 0.00 N.A. 80.20 0.00 0.00
251 Zydus Wellness Limited Mr. Umesh V. Parikh Key Managerial Personnel Remuneration 0.00 N.A. 126.10 0.00 0.00
252 Zydus Wellness Limited Mr. Nandish P. Joshi Key Managerial Personnel Remuneration 0.00 N.A. 10.20 0.00 0.00
253 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Interest received 0.00 N.A. 112.00 0.00 0.00
254 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Loan 0.00 N.A. 2,183.40 0.00 0.00 Loan 2.8500 5 Year Unsecured Business Purpose Textual Information(9)
255 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Loan 0.00 N.A. 2,081.70 0.00 0.00
256 Zydus Pharmaceuticals Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of fixed assets 0.00 N.A. 79.80 0.00 0.00
257 Zydus Wellness Limited Zydus Wellness Limited Employees Group Gratuity Scheme Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 0.00 N.A. 253.30 0.00 0.00
258 Zydus Wellness Limited Apollo Healthco Limited Enterprises significantly influenced by Directors and/ or their relatives Sale of goods or services 127.90 Amount as approved by the Audit Committee. 127.90 0.00 0.00
259 Zydus Wellness Limited Apollo Healthco Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Reimbursement of Expenses paid 3.80 Amount as approved by the Audit Committee. 3.80 0.00 0.00
260 Zydus Wellness Limited Apollo Healthco Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 0.30
261 Zydus Wellness Limited TUV India Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.50 Amount as approved by the Audit Committee. 0.50 0.00 0.00
262 Zydus Wellness Products Limited Apollo Healthco Limited Enterprises significantly influenced by Directors and/ or their relatives Sale of goods or services 0.00 N.A. 3,601.50 0.00 0.00
263 Zydus Wellness Products Limited Apollo Healthco Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Reimbursement of Expenses paid 0.00 N.A. 1,037.30 0.00 0.00
264 Zydus Wellness Products Limited Apollo Healthco Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 560.90
265 Zydus Wellness Products Limited Indifoss Analytical Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 11.30 0.00 0.00
266 Zydus Wellness Products Limited Indifoss Analytical Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 3.30 0.00 0.00
267 Zydus Wellness Products Limited Indifoss Analytical Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 0.40
268 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 3,590.00 3,792.00
269 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 547.10 0.00
270 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 11,326.20 12,900.00
271 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 1,566.90
272 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 447.20 408.80
273 Zydus Wellness Products Limited Zydus Healthcare Limited Subsidiary Company Purchase of goods or services 0.00 N.A. 631.40 0.00 0.00
274 Zydus Wellness Products Limited Mukesh M. Patel & Co., Proprietorship Firm Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 10.00 0.00 0.00
275 Zydus Wellness Products Limited Mr. Tarun Arora Key Managerial Personnel Remuneration 0.00 N.A. 419.80 0.00 0.00
276 Zydus Wellness Products Limited Zydus Wellness International DMCC Subsidiary Company Sale of goods or services 0.00 N.A. 1,718.40 0.00 0.00
277 Zydus Wellness Products Limited Zydus Healthcare Limited Subsidiary Company Sale of goods or services 0.00 N.A. 113.50 0.00 0.00
278 Zydus Wellness Products Limited Zydus Wellness International DMCC Subsidiary Company Sale of goods or services 0.00 N.A. 14.80 0.00 0.00
279 Zydus Wellness Products Limited Zydus Healthcare Limited Subsidiary Company Sale of goods or services 0.00 N.A. 70.90 0.00 0.00
280 Zydus Wellness Products Limited Zydus Wellness International DMCC Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 114.70 0.00 0.00
281 Zydus Wellness Products Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 11.80 0.00 0.00
282 Zydus Wellness Products Limited Zydus Wellness BD Private Limited Subsidiary Company Investment 0.00 N.A. 377.10 0.00 377.10 Investment 0 N.A Unsecured Business Purpose Textual Information(10)
283 Zydus Wellness Products Limited LM Manufacturing India Private Limited Subsidiary Company Sale of goods or services 0.00 N.A. 25.40 0.00 0.00
284 Zydus Wellness Products Limited LM Manufacturing India Private Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 3.20 0.00 0.00
285 Zydus Wellness Products Limited LM Manufacturing India Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 1.50 0.70
286 Zydus Wellness Products Limited Heinz India Private Limited Pension Fund Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 0.00 N.A. 14.50 0.00 0.00
287 Zydus Wellness Products Limited Zydus Wellness Sikkim Employees Group Gratuity Scheme Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 0.00 N.A. 200.00 0.00 0.00
288 Zydus Wellness Products Limited Zydus Medtech Private Limited Subsidiary Company Sale of goods or services 0.00 N.A. 32.00 0.00 0.00
289 Zydus Wellness Products Limited Zydus Medtech Private Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 3.30 0.00 0.00
290 Zydus Wellness Products Limited Zydus Medtech Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 3.90
291 Zydus Wellness Products Limited Zydus Wellness International DMCC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 1,762.10 2,671.80
292 Zydus Wellness Products Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 172.00 88.10
293 German Remedies Pharma Private Limited German Remedies Pharmaceuticals Private Limited Emp Group Gratuity Scheme Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 0.00 N.A. 92.00 0.00 0.00
294 German Remedies Pharma Private Limited Zydus Healthcare Limited Subsidiary Company Sale of goods or services 0.00 N.A. 1,735.60 0.00 0.00
295 German Remedies Pharma Private Limited Zydus Foundation Enterprises significantly influenced by Directors and/ or their relatives Sale of goods or services 0.00 N.A. 25.30 0.00 0.00
296 German Remedies Pharma Private Limited Zydus Foundation Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 5.90 0.00
297 German Remedies Pharma Private Limited Zydus Foundation Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Corporate Social Responsibility (CSR) Expenses 0.00 N.A. 129.60 0.00 0.00
298 German Remedies Pharma Private Limited Recon Pharmaceuticals and Investments Subsidiary Company Any other transaction Share of profit Received 0.00 N.A. 0.10 0.00 0.00
299 German Remedies Pharma Private Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 175.50 83.30
300 Zydus Pharmaceuticals Limited Mukesh M. Patel & Co., Proprietorship Firm Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 2.20 0.00 0.00
301 Zydus Pharmaceuticals Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 206.50 0.00 0.00
302 Zydus Pharmaceuticals Limited Zydus Animal Health and Investments Limited Subsidiary Company Sale of goods or services 0.00 N.A. 2.50 0.00 0.00
303 Zydus Pharmaceuticals Limited Zydus Animal Health and Investments Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 2.50
304 Zydus Pharmaceuticals Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Sale of goods or services 0.00 N.A. 962.30 0.00 0.00
305 Zydus Pharmaceuticals Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 87.60 91.00
306 Zydus Pharmaceuticals Limited Zydus Pharmaceuticals Limited Employees Group Gratuity Scheme Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 0.00 N.A. 203.50 0.00 0.00
307 Zydus Pharmaceuticals Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 44.70 1,007.00
308 Zydus Animal Health and Investments Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 1.30 0.00 0.00
309 Zydus Animal Health and Investments Limited Zydus Animal Health And Investment Ltd. Employees Group Gratuity Scheme Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 0.00 N.A. 7.00 0.00 0.00
310 Zydus Animal Health and Investments Limited Dialforhealth Unity Limited Subsidiary Company Interest received 0.00 N.A. 0.00 0.00 0.00
311 Zydus Animal Health and Investments Limited Dialforhealth Unity Limited Subsidiary Company Loan 0.00 N.A. 1.00 0.00 0.00 Loan 1.200 5 Year Unsecured Business Purpose Textual Information(11)
312 Zydus Animal Health and Investments Limited Dialforhealth Unity Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 1.10 2.10
313 Zydus Animal Health and Investments Limited Biochem Pharmaceutical Private Limited Subsidiary Company Investment 0.00 N.A. 0.00 5.00 0.00
314 Zydus Animal Health and Investments Limited Zydus Medtech Private Limited Subsidiary Company Loan 0.00 N.A. 29,997.50 0.00 0.00
315 Zydus Animal Health and Investments Limited Zydus Medtech Private Limited Subsidiary Company Interest received 0.00 N.A. 998.90 0.00 0.00
316 Zydus Animal Health and Investments Limited Zydus Medtech Private Limited Subsidiary Company Loan 0.00 N.A. 40,000.00 0.00 0.00 Loan 0.8500 5 Year Unsecured Business Purpose Textual Information(12)
317 Zydus Animal Health and Investments Limited Zydus Medtech Private Limited Subsidiary Company Loan 0.00 N.A. 5,555.80 0.00 0.00 Loan 1.200 5 Year Unsecured Business Purpose Textual Information(13)
318 Zydus Animal Health and Investments Limited Zydus Medtech Private Limited Subsidiary Company Loan 0.00 N.A. 4,485.00 0.00 0.00 Loan 0.8500 5 Year Unsecured Business Purpose Textual Information(14)
319 Zydus Animal Health and Investments Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 16.20 0.00 0.00
320 Zydus Animal Health and Investments Limited ZyVet Animal Health Inc Subsidiary Company Sale of goods or services 0.00 N.A. 5,733.80 0.00 0.00
321 Zydus Animal Health and Investments Limited Viona Pharmaceuticals INC Subsidiary Company Interest received 0.00 N.A. 100.90 0.00 0.00
322 Zydus Animal Health and Investments Limited Zydus Foundation Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Corporate Social Responsibility (CSR) Expenses 0.00 N.A. 261.00 0.00 0.00
323 Zydus Animal Health and Investments Limited Zydus Lifesciences Limited Parent Company Loan 0.00 N.A. 7,221.00 0.00 0.00 Loan 1.200 5 Year Unsecured Business Purpose Textual Information(15)
324 Zydus Animal Health and Investments Limited Zydus Lifesciences Limited Parent Company Loan 0.00 N.A. 31,709.00 0.00 0.00 Loan 0.900 5 Year Unsecured Business Purpose Textual Information(16)
325 Zydus Animal Health and Investments Limited Mukesh M. Patel & Co., Proprietorship Firm Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 2.20 0.00 0.00
326 Zydus Animal Health and Investments Limited ZyVet Animal Health Inc Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 4,029.70 2,375.10
327 Zydus Animal Health and Investments Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 3.70 0.00 0.00
328 Zydus Animal Health and Investments Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 4.90 0.40
329 Zydus Animal Health and Investments Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 25.90 11.50
330 Zydus Animal Health and Investments Limited Viona Pharmaceuticals INC Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 4,438.50 4,740.00
331 Zydus Animal Health and Investments Limited Zydus Medtech Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 20,362.90 40,389.90
332 Zydus Animal Health and Investments Limited ZyVet Animal Health Inc Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 4,280.40 4,868.60
333 Dialforhealth Unity Limited Dialforhealth Greencross Limited Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 N.A. 0.10 0.00 0.00
334 Dialforhealth Unity Limited Dialforhealth Greencross Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 0.10
335 Zydus Pharmaceuticals (USA) Inc. NAI Laboratories Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 763.50 0.00 0.00
336 Zydus Pharmaceuticals (USA) Inc. Navinta III, Inc Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 589.40 0.00 0.00
337 Zydus Pharmaceuticals (USA) Inc. Navinta LLC Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 1,355.40 0.00 0.00
338 Zydus Pharmaceuticals (USA) Inc. Navinta NV, Inc. Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 1,796.20 0.00 0.00
339 Zydus Pharmaceuticals (USA) Inc. Zydus Healthcare (USA) LLC Subsidiary Company Loan 0.00 N.A. 239.90 0.00 0.00
340 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Sale of goods or services 0.00 N.A. 96.30 0.00 0.00
341 Zydus Pharmaceuticals (USA) Inc. Viona Pharmaceuticals INC Subsidiary Company Sale of goods or services 0.00 N.A. 251.30 0.00 0.00
342 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Sale of goods or services 0.00 N.A. 85.10 0.00 0.00
343 Zydus Pharmaceuticals (USA) Inc. Zydus Lifesciences Global FZE [UAE] Subsidiary Company Purchase of goods or services 0.00 N.A. 43,636.10 0.00 0.00
344 Zydus Pharmaceuticals (USA) Inc. Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 11,479.50 0.00 0.00
345 Zydus Pharmaceuticals (USA) Inc. Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 793.90 1,561.20
346 Zydus Pharmaceuticals (USA) Inc. Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 51,094.30 6,289.10
347 Zydus Pharmaceuticals (USA) Inc. Zydus Healthcare (USA) LLC Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 53.00 0.00 0.00
348 Zydus Pharmaceuticals (USA) Inc. Zydus Therapeutics INC Subsidiary Company Sale of goods or services 0.00 N.A. 245.80 0.00 0.00
349 Zydus Pharmaceuticals (USA) Inc. Navinta LLC Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Reimbursement of Expenses paid 0.00 N.A. 82.30 0.00 0.00
350 Zydus Pharmaceuticals (USA) Inc. Navinta LLC Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 11.00 0.00 0.00
351 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 28.20 0.00 0.00
352 Zydus Pharmaceuticals (USA) Inc. Viona Pharmaceuticals INC Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 49.10 0.00 0.00
353 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 16.90 0.00 0.00
354 Zydus Pharmaceuticals (USA) Inc. Zydus Therapeutics INC Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 3.70 0.00 0.00
355 Zydus Pharmaceuticals (USA) Inc. Zynext Ventures USA LLC Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 2.00 0.00 0.00
356 Zydus Pharmaceuticals (USA) Inc. Zydus Healthcare (USA) LLC Subsidiary Company Loan 0.00 N.A. 635.10 0.00 0.00 Loan 0.500 1 Year Unsecured Business Purpose Textual Information(17)
357 Zydus Pharmaceuticals (USA) Inc. Zydus Healthcare (USA) LLC Subsidiary Company Interest received 0.00 N.A. 4.50 0.00 0.00
358 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 N.A. 20.70 0.00 0.00
359 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Interest received 0.00 N.A. 653.60 0.00 0.00
360 Zydus Pharmaceuticals (USA) Inc. Viona Pharmaceuticals INC Subsidiary Company Interest received 0.00 N.A. 334.10 0.00 0.00
361 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Interest received 0.00 N.A. 127.70 0.00 0.00
362 Zydus Pharmaceuticals (USA) Inc. Zydus Therapeutics INC Subsidiary Company Interest received 0.00 N.A. 2,540.40 0.00 0.00
363 Zydus Pharmaceuticals (USA) Inc. Zydus Pharmaceuticals Canada Inc. Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 0.50 0.00 0.00
364 Zydus Pharmaceuticals (USA) Inc. Zydus Pharmaceuticals Canada Inc. Subsidiary Company Sale of goods or services 0.00 N.A. 143.90 0.00 0.00
365 Zydus Pharmaceuticals (USA) Inc. Zydus Pharmaceuticals Canada Inc. Subsidiary Company Interest received 0.00 N.A. 28.90 0.00 0.00
366 Zydus Pharmaceuticals (USA) Inc. Zydus Pharmaceuticals Canada Inc. Subsidiary Company Loan 0.00 N.A. 274.30 0.00 0.00 Loan 0.500 1 Year Unsecured Business Purpose Textual Information(18)
367 Zydus Pharmaceuticals (USA) Inc. Zydus Pharmaceuticals Canada Inc. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 976.90 1,328.20
368 Zydus Pharmaceuticals (USA) Inc. Zydus Pharmaceuticals Canada Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 12.10 36.30
369 Zydus Pharmaceuticals (USA) Inc. Viona Pharmaceuticals INC Subsidiary Company Loan 0.00 N.A. 8,471.40 0.00 0.00 Loan 0.500 1 Year Unsecured Business Purpose Textual Information(19)
370 Zydus Pharmaceuticals (USA) Inc. Zydus Therapeutics INC Subsidiary Company Loan 0.00 N.A. 26,258.10 0.00 0.00 Loan 0.500 1 Year Unsecured Business Purpose Textual Information(20)
371 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Loan 0.00 N.A. 2,208.30 0.00 0.00 Loan 0.500 1 Year Unsecured Business Purpose Textual Information(21)
372 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Loan 0.00 N.A. 839.10 0.00 0.00
373 Zydus Pharmaceuticals (USA) Inc. Zynext Ventures USA LLC Subsidiary Company Loan 0.00 N.A. 11,482.90 0.00 0.00 Loan 0.500 1 Year Unsecured Business Purpose Textual Information(22)
374 Zydus Pharmaceuticals (USA) Inc. Zynext Ventures USA LLC Subsidiary Company Loan 0.00 N.A. 11,482.90 0.00 0.00
375 Zydus Pharmaceuticals (USA) Inc. Zynext Ventures USA LLC Subsidiary Company Interest received 0.00 N.A. 104.40 0.00 0.00
376 Zydus Pharmaceuticals (USA) Inc. NAI Laboratories Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 265.30 232.00
377 Zydus Pharmaceuticals (USA) Inc. Navinta III, Inc Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 746.80 1,826.00
378 Zydus Pharmaceuticals (USA) Inc. Navinta LLC Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 1,327.60 55.40
379 Zydus Pharmaceuticals (USA) Inc. Navinta NV, Inc. Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 985.30 141.40
380 Zydus Pharmaceuticals (USA) Inc. Zydus Healthcare (USA) LLC Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 0.00 474.40
381 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 28,761.80 33,077.60
382 Zydus Pharmaceuticals (USA) Inc. Viona Pharmaceuticals INC Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 11,932.90 21,797.30
383 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 5,861.50 5,360.20
384 Zydus Pharmaceuticals (USA) Inc. Zydus Therapeutics INC Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 99,490.80 1,34,141.00
385 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 24.40 38.70
386 Zydus Pharmaceuticals (USA) Inc. Viona Pharmaceuticals INC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 71.40 187.40
387 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 38.80 115.50
388 Zydus Pharmaceuticals (USA) Inc. Zylidac Bio LLC, USA Subsidiary Company Loan 0.00 N.A. 76,815.20 0.00 0.00 Loan 0.500 1 Year Unsecured Business Purpose Textual Information(23)
389 Zydus Pharmaceuticals (USA) Inc. Zylidac Bio LLC, USA Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 1,430.30 0.00 0.00
390 Zydus Pharmaceuticals (USA) Inc. Zylidac Bio LLC, USA Subsidiary Company Interest received 0.00 N.A. 687.40 0.00 0.00
391 Zydus Pharmaceuticals (USA) Inc. Zylidac Bio LLC, USA Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 5.90 84,783.30
392 Zydus Pharmaceuticals (USA) Inc. Zynext Ventures USA LLC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 2.10
393 Zydus Pharmaceuticals (USA) Inc. Zydus Therapeutics INC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 387.20 559.20
394 Zydus Worldwide DMCC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 N.A. 1,249.50 0.00 0.00
395 Zydus Worldwide DMCC Zydus Healthcare (USA) LLC Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 N.A. 7.30 0.00 0.00
396 Zydus Worldwide DMCC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Sale of goods or services 0.00 N.A. 4,511.70 0.00 0.00
397 Zydus Worldwide DMCC Zydus Netherlands B.V. Subsidiary Company Interest received 0.00 N.A. 220.40 0.00 0.00
398 Zydus Worldwide DMCC Alidac Healthcare (Myanmar) Limited Subsidiary Company Interest received 0.00 N.A. 71.80 0.00 0.00
399 Zydus Worldwide DMCC Zydus Netherlands B.V. Subsidiary Company Investment 0.00 N.A. 13,251.70 102.30 13,354.00 Investment 0 N.A Unsecured Business Purpose Textual Information(24)
400 Zydus Worldwide DMCC Zydus France, SAS Subsidiary Company Interest received 0.00 N.A. 18.40 0.00 0.00
401 Zydus Worldwide DMCC Zydus France, SAS Subsidiary Company Loan 0.00 N.A. 2,202.00 0.00 0.00
402 Zydus Worldwide DMCC Zydus France, SAS Subsidiary Company Investment 0.00 N.A. 4,365.00 0.00 4,365.00 Investment 0 N.A Unsecured Business Purpose Textual Information(25)
403 Zydus Worldwide DMCC Zydus France, SAS Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 2,284.90 0.00
404 Zydus Worldwide DMCC Zydus International Private Limited Subsidiary Company Interest received 0.00 N.A. (911.10) 0.00 0.00
405 Zydus Worldwide DMCC Alidac Healthcare (Myanmar) Limited Subsidiary Company Loan 0.00 N.A. 5,133.90 0.00 0.00
406 Zydus Worldwide DMCC Alidac Healthcare (Myanmar) Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 5,873.20 0.00
407 Zydus Worldwide DMCC Zydus Netherlands B.V. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 10,437.30 11,380.90
408 Zydus Worldwide DMCC Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 1.10 0.00
409 Zydus Worldwide DMCC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 1,791.10 7.80
410 Zydus Worldwide DMCC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 7,967.70 7,431.30
411 Zydus Healthcare (USA) LLC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Purchase of goods or services 0.00 N.A. 13.80 0.00 0.00
412 Zydus Healthcare (USA) LLC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Sale of goods or services 0.00 N.A. 208.10 0.00 0.00
413 Zydus Healthcare (USA) LLC Zydus Therapeutics INC Subsidiary Company Sale of goods or services 0.00 N.A. 34.40 0.00 0.00
414 Zydus Healthcare (USA) LLC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 34.20 0.00
415 Zydus Healthcare (USA) LLC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 1.10 17.30
416 Zydus Healthcare (USA) LLC Zydus Therapeutics INC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 1.10 0.00
417 Zydus Healthcare (USA) LLC Zydus Worldwide DMCC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 15.50 0.00
418 ZyVet Animal Health Inc Zydus Animal Health and Investments Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 760.90 0.00 0.00
419 Zydus Wellness International DMCC Zydus Worldwide DMCC Subsidiary Company Purchase of goods or services 0.00 N.A. 5.30 0.00 0.00
420 Zydus Wellness International DMCC Zydus Worldwide DMCC Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 11.00 0.00 0.00
421 Zydus Wellness International DMCC Zydus Worldwide DMCC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 12.20
422 Zydus Wellness International DMCC Zydus Worldwide DMCC Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 8.70 0.00
423 Zydus International Private Limited RIC Chemicals LTD Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 9.10 0.00 0.00
424 Zydus International Private Limited Zydus Netherlands B.V. Subsidiary Company Interest received 0.00 N.A. 53.00 0.00 0.00
425 Zydus International Private Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Interest received 0.00 N.A. 45.70 0.00 0.00
426 Zydus International Private Limited Zydus France, SAS Subsidiary Company Interest received 0.00 N.A. 53.40 0.00 0.00
427 Zydus International Private Limited Laboratorios Combix S.L. Subsidiary Company Interest received 0.00 N.A. 48.20 0.00 0.00
428 Zydus International Private Limited Zydus Worldwide DMCC Subsidiary Company Loan 0.00 N.A. 4,594.60 0.00 0.00
429 Zydus International Private Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Loan 0.00 N.A. 3,552.00 0.00 0.00 Loan 0.8500 5 Year Unsecured Business Purpose Textual Information(26)
430 Zydus International Private Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Loan 0.00 N.A. 7,439.90 0.00 0.00
431 Zydus International Private Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Interest received 0.00 N.A. 4,196.60 0.00 0.00
432 Zydus International Private Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 1,82,204.40 1,86,215.30
433 Zydus International Private Limited Zydus Worldwide DMCC Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 4,270.50 0.00
434 Zydus International Private Limited Zydus Netherlands B.V. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 2,935.40 3,118.50
435 Zydus International Private Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 4,186.20 4,416.50
436 Zydus International Private Limited Zydus France, SAS Subsidiary Company Loan 0.00 N.A. 1,889.40 0.00 0.00
437 Zydus International Private Limited Zydus France, SAS Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 5,034.40 3,016.90
438 Zydus International Private Limited Laboratorios Combix S.L. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 3,851.10 4,069.20
439 Zydus Netherlands B.V. Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Investment 0.00 N.A. 13,301.90 0.00 13,301.90 Investment 0 N.A Unsecured Business Purpose Textual Information(27)
440 Zydus France, SAS Laboratorios Combix S.L. Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 N.A. 7.60 0.00 0.00
441 Zydus France, SAS Laboratorios Combix S.L. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 3.60 0.00
442 Zydus Healthcare S.A. (Pty) Ltd Alidac Pharmaceuticals SA (Pty) Ltd Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 4,661.20 4,995.80
443 Zydus Healthcare S.A. (Pty) Ltd Alidac Pharmaceuticals SA (Pty) Ltd Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 566.30 606.90
444 Script Management Services (Pty) Ltd Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Sale of goods or services 0.00 N.A. 4,909.10 0.00 0.00
445 Script Management Services (Pty) Ltd Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 1.00 0.00 0.00
446 Script Management Services (Pty) Ltd Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 145.20 245.40
447 Zydus Healthcare Philippines Inc. RJ Conception Law Office Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 0.90 0.00 0.00
448 Alidac Healthcare (Myanmar) Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 21.00 0.00 0.00
449 Zynext Ventures Pte. Ltd. Zynext Ventures USA LLC Subsidiary Company Investment 0.00 N.A. 12,587.00 0.00 12,587.00 Investment 0 N.A Unsecured Business Purpose Textual Information(28)
450 Zydus Pharmaceuticals UK Ltd. LiqMeds Limited Subsidiary Company Interest received 0.00 N.A. 252.20 0.00 0.00
451 Zydus Pharmaceuticals UK Ltd. LM Manufacturing Limited Subsidiary Company Interest received 0.00 N.A. 205.00 0.00 0.00
452 Zydus Pharmaceuticals UK Ltd. Zydus France, SAS Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 N.A. 2.50 0.00 0.00
453 Zydus Pharmaceuticals UK Ltd. LM Manufacturing Limited Subsidiary Company Loan 0.00 N.A. 4,480.80 0.00 0.00
454 Zydus Pharmaceuticals UK Ltd. LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 638.70 38.80
455 Zydus Pharmaceuticals UK Ltd. LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 9,108.00 5,054.60
456 Zydus Pharmaceuticals UK Ltd. LiqMeds Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 8,555.10 8,945.30
457 Zydus Lifesciences Global FZE [UAE] Zydus Lifesciences Limited Parent Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 50,540.10 54,920.60
458 Zydus Lifesciences Global FZE [UAE] Zydus Worldwide DMCC Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 475.10
459 Zydus Lifesciences Global FZE [UAE] Viona Pharmaceuticals INC Subsidiary Company Sale of goods or services 0.00 N.A. 4,602.80 0.00 0.00
460 Zydus Lifesciences Global FZE [UAE] Zydus Healthcare (USA) LLC Subsidiary Company Purchase of goods or services 0.00 N.A. 399.10 0.00 0.00
461 Zydus Lifesciences Global FZE [UAE] Zydus Healthcare (USA) LLC Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 N.A. 241.10 0.00 0.00
462 Zydus Lifesciences Global FZE [UAE] Zydus Healthcare (USA) LLC Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 222.70 36.20
463 Zydus Lifesciences Global FZE [UAE] Viona Pharmaceuticals INC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 2,665.20 2,792.90
464 LM Manufacturing Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 208.90 0.00 0.00
465 LM Manufacturing Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Sale of goods or services 0.00 N.A. 33.60 0.00 0.00
466 LiqMeds Worldwide Limited LiqMeds Lifecare Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 197.70 207.10
467 LiqMeds Worldwide Limited LiqMeds Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 435.50 731.50
468 LM Manufacturing Limited Oncosol Limited Joint Ventures Sale of goods or services 0.00 N.A. 15.00 0.00 0.00
469 LM Manufacturing India Private Limited LM Manufacturing Limited Subsidiary Company Sale of goods or services 0.00 N.A. 384.30 0.00 0.00
470 LiqMeds Worldwide Limited LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 24,005.00 40,019.50
471 LiqMeds Worldwide Limited Oncosol Limited Joint Ventures Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 2.10 0.00
472 LM Manufacturing Limited Medsolutions (Europe) Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 17.70 18.60
473 LM Manufacturing Limited Oncosol Limited Joint Ventures Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 16.20 32.70
474 LiqMeds Limited LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 4,847.70 7,281.70
475 LiqMeds Lifecare Limited LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 382.90 1,264.50
476 LM Manufacturing India Private Limited LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 92.30 78.40
477 LiqMeds Lifecare Limited LiqMeds Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 10.70 11.20
478 LiqMeds Lifecare Limited Medsolutions (Europe) Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 107.50 112.60
479 LiqMeds Lifecare Limited Oncosol Limited Joint Ventures Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 1,173.10 359.20
480 Medsolutions (Europe) Limited LiqMeds Worldwide Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 138.00 144.60
481 Medsolutions (Europe) Limited Oncosol Limited Joint Ventures Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 5.20 5.40
482 Zydus Medtech Private Limited Zydus Medtech France SAS Subsidiary Company Investment 0.00 N.A. 0.00 2,020.30 0.00
483 Zydus Medtech Private Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 0.00 0.00 0.00
484 Zydus Medtech Private Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 0.50 0.00 0.00
485 Zydus Worldwide DMCC Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 N.A. 21.90 0.00 0.00
486 Zydus Healthcare S.A. (Pty) Ltd DI Consultancy Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 99.30 0.00 0.00
487 Zydus Medtech France SAS Amplitude Surgical SAS Subsidiary Company Interest received 0.00 N.A. 1,338.40 0.00 0.00
488 Zydus Medtech France SAS Amplitude SAS [France] Subsidiary Company Loan 0.00 N.A. 10,759.40 0.00 0.00
489 Zydus Medtech France SAS Amplitude Surgical SAS Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 76,055.30 79,382.20
490 Zydus Medtech France SAS Amplitude SAS [France] Subsidiary Company Loan 0.00 N.A. 3,442.80 0.00 0.00 Loan 1.500 7 Year Unsecured Business Purpose Textual Information(29)
491 Zydus Medtech France SAS Amplitude SAS [France] Subsidiary Company Interest received 0.00 N.A. 293.30 0.00 0.00
492 Zydus Medtech France SAS Amplitude SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 13,811.20 6,258.10
493 Amplitude SAS [France] SCI Les Tilleuls [France] Subsidiary Company Purchase of goods or services 0.00 N.A. 572.20 0.00 0.00
494 Amplitude SAS [France] SCI SOFAB FALLA [France] Subsidiary Company Purchase of goods or services 0.00 N.A. 295.70 0.00 0.00
495 Amplitude SAS [France] Amplitude Ile de France [France] Subsidiary Company Purchase of goods or services 0.00 N.A. 1,248.10 0.00 0.00
496 Amplitude SAS [France] Duotech Amplitude SAS [France] Subsidiary Company Purchase of goods or services 0.00 N.A. 641.50 0.00 0.00
497 Amplitude SAS [France] Amplitude Sud SAS [France] Subsidiary Company Purchase of goods or services 0.00 N.A. 710.60 0.00 0.00
498 Amplitude SAS [France] Amplitude Nord SAS [France] Subsidiary Company Purchase of goods or services 0.00 N.A. 825.10 0.00 0.00
499 Amplitude SAS [France] Ortho Sant� (Amplitude Ouest) [France] Subsidiary Company Purchase of goods or services 0.00 N.A. 1,058.80 0.00 0.00
500 Amplitude SAS [France] Amplitude Australia Pty Ltd [Australia] Subsidiary Company Sale of goods or services 0.00 N.A. 1,675.50 0.00 0.00
501 Amplitude SAS [France] Amplitude South Africa Pty Ltd [South Africa] Subsidiary Company Sale of goods or services 0.00 N.A. 435.50 0.00 0.00
502 Amplitude SAS [France] Amplitude Latin America SA [Brazil] Subsidiary Company Sale of goods or services 0.00 N.A. 1,977.60 0.00 0.00
503 Amplitude SAS [France] Amplitude Benelux [Belgium] Subsidiary Company Sale of goods or services 0.00 N.A. 1,423.10 0.00 0.00
504 Amplitude SAS [France] Amplitude Suisse SA [Switzerland] Subsidiary Company Sale of goods or services 0.00 N.A. 228.80 0.00 0.00
505 Amplitude SAS [France] Amplitude GmbH [Germany] Subsidiary Company Sale of goods or services 0.00 N.A. 170.50 0.00 0.00
506 Amplitude SAS [France] Amplitude Ile de France [France] Subsidiary Company Sale of goods or services 0.00 N.A. 74.60 0.00 0.00
507 Amplitude SAS [France] Amplitude Sud SAS [France] Subsidiary Company Sale of goods or services 0.00 N.A. 24.70 0.00 0.00
508 Amplitude SAS [France] Amplitude Nord SAS [France] Subsidiary Company Sale of goods or services 0.00 N.A. 25.90 0.00 0.00
509 Amplitude SAS [France] Ortho Sant� (Amplitude Ouest) [France] Subsidiary Company Sale of goods or services 0.00 N.A. 27.80 0.00 0.00
510 Amplitude SAS [France] Amplitude Benelux [Belgium] Subsidiary Company Sale of goods or services 0.00 N.A. 202.60 0.00 0.00
511 Amplitude SAS [France] Amplitude Orthopedics Corporation [USA] Subsidiary Company Interest received 0.00 N.A. 64.10 0.00 0.00
512 Amplitude SAS [France] Amplitude Australia Pty Ltd [Australia] Subsidiary Company Sale of goods or services 0.00 N.A. 15.40 0.00 0.00
513 Amplitude SAS [France] Amplitude Australia Pty Ltd [Australia] Subsidiary Company Interest received 0.00 N.A. 207.80 0.00 0.00
514 Amplitude SAS [France] Amplitude South Africa Pty Ltd [South Africa] Subsidiary Company Interest received 0.00 N.A. 71.30 0.00 0.00
515 Amplitude SAS [France] Amplitude Benelux [Belgium] Subsidiary Company Interest received 0.00 N.A. 33.10 0.00 0.00
516 Amplitude SAS [France] Amplitude Suisse SA [Switzerland] Subsidiary Company Interest received 0.00 N.A. 13.50 0.00 0.00
517 Amplitude SAS [France] Amplitude GmbH [Germany] Subsidiary Company Interest received 0.00 N.A. 14.50 0.00 0.00
518 Amplitude SAS [France] SCI Les Tilleuls [France] Subsidiary Company Interest paid 0.00 N.A. 44.50 0.00 0.00
519 Amplitude SAS [France] SCI SOFAB FALLA [France] Subsidiary Company Interest paid 0.00 N.A. 1.10 0.00 0.00
520 Amplitude SAS [France] Amplitude Ile de France [France] Subsidiary Company Interest paid 0.00 N.A. 2.70 0.00 0.00
521 Amplitude SAS [France] Duotech Amplitude SAS [France] Subsidiary Company Interest paid 0.00 N.A. 3.10 0.00 0.00
522 Amplitude SAS [France] Amplitude Sud SAS [France] Subsidiary Company Interest paid 0.00 N.A. 8.30 0.00 0.00
523 Amplitude SAS [France] Amplitude Nord SAS [France] Subsidiary Company Interest paid 0.00 N.A. 3.10 0.00 0.00
524 Amplitude SAS [France] Ortho Sant� (Amplitude Ouest) [France] Subsidiary Company Interest paid 0.00 N.A. 6.20 0.00 0.00
525 Amplitude SAS [France] Amplitude New Zealand, New Zealand Subsidiary Company Sale of goods or services 0.00 N.A. 299.20 0.00 0.00
526 Amplitude SAS [France] Amplitude New Zealand, New Zealand Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 0.00 108.80
527 Amplitude SAS [France] Amplitude New Zealand, New Zealand Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 311.10
528 Amplitude SAS [France] SCI Les Tilleuls [France] Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 2,890.00 3,467.90
529 Amplitude SAS [France] SCI SOFAB FALLA [France] Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 108.40 102.30
530 Amplitude SAS [France] Amplitude Ile de France [France] Subsidiary Company Dividend received 0.00 N.A. 327.90 0.00 0.00
531 Amplitude SAS [France] Amplitude Ile de France [France] Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 353.30 174.00
532 Amplitude SAS [France] Mediconseil Subsidiary Company Purchase of goods or services 0.00 N.A. 401.70 0.00 0.00
533 Amplitude SAS [France] Mediconseil Subsidiary Company Sale of goods or services 0.00 N.A. 7.20 0.00 0.00
534 Amplitude SAS [France] Mediconseil Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 0.00 407.90
535 Amplitude SAS [France] Mediconseil Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 380.70
536 Amplitude SAS [France] Mediconseil Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 5.40
537 Amplitude SAS [France] Duotech Amplitude SAS [France] Subsidiary Company Sale of goods or services 0.00 N.A. 5.10 0.00 0.00
538 Amplitude SAS [France] Duotech Amplitude SAS [France] Subsidiary Company Dividend received 0.00 N.A. 256.20 0.00 0.00
539 Amplitude SAS [France] Duotech Amplitude SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 0.00 12.00
540 Amplitude SAS [France] Duotech Amplitude SAS [France] Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 402.30 0.00
541 Amplitude SAS [France] Amplitude Sud SAS [France] Subsidiary Company Dividend received 0.00 N.A. 461.20 0.00 0.00
542 Amplitude SAS [France] Amplitude Sud SAS [France] Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 790.00 505.80
543 Amplitude SAS [France] Amplitude Nord SAS [France] Subsidiary Company Dividend received 0.00 N.A. 205.00 0.00 0.00
544 Amplitude SAS [France] Amplitude Nord SAS [France] Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 302.20 194.70
545 Amplitude SAS [France] Ortho Sant� (Amplitude Ouest) [France] Subsidiary Company Dividend received 0.00 N.A. 358.70 0.00 0.00
546 Amplitude SAS [France] Ortho Sant� (Amplitude Ouest) [France] Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 683.70 249.10
547 Amplitude SAS [France] Amplitude Latin America SA [Brazil] Subsidiary Company Sale of goods or services 0.00 N.A. 7.20 0.00 0.00
548 Amplitude SAS [France] Amplitude Latin America SA [Brazil] Subsidiary Company Dividend received 0.00 N.A. 3,255.80 0.00 0.00
549 Amplitude SAS [France] Amplitude Latin America SA [Brazil] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 2.10 0.00
550 Amplitude SAS [France] SCI Les Tilleuls [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 140.70 28.30
551 Amplitude SAS [France] SCI SOFAB FALLA [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 42.70 50.00
552 Amplitude SAS [France] Amplitude Ile de France [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 406.50 738.60
553 Amplitude SAS [France] Duotech Amplitude SAS [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 188.60 324.20
554 Amplitude SAS [France] Amplitude Sud SAS [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 300.20 357.90
555 Amplitude SAS [France] Amplitude Nord SAS [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 336.60 461.20
556 Amplitude SAS [France] Ortho Sant� (Amplitude Ouest) [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 380.40 517.80
557 Amplitude SAS [France] Amplitude Orthopedics Corporation [USA] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 6,380.30 6,851.00
558 Amplitude SAS [France] Amplitude Australia Pty Ltd [Australia] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 20,352.10 22,479.40
559 Amplitude SAS [France] Amplitude South Africa Pty Ltd [South Africa] Subsidiary Company Sale of goods or services 0.00 N.A. 1.00 0.00 0.00
560 Amplitude SAS [France] Amplitude South Africa Pty Ltd [South Africa] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 4,919.20 5,069.10
561 Amplitude SAS [France] SCI Les Tilleuls [France] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 224.10 233.90
562 Amplitude SAS [France] Amplitude Benelux [Belgium] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 2,208.40 2,338.80
563 Amplitude SAS [France] Amplitude Suisse SA [Switzerland] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 1,367.40 1,451.10
564 Amplitude SAS [France] Amplitude GmbH [Germany] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 978.60 1,107.40
565 Amplitude SAS [France] Amplitude Australia Pty Ltd [Australia] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 992.20 872.40
566 Amplitude SAS [France] Amplitude South Africa Pty Ltd [South Africa] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 115.70 140.30
567 Amplitude SAS [France] Amplitude Latin America SA [Brazil] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 2,406.40 6,013.40
568 Amplitude SAS [France] Amplitude Ile de France [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 20.80 45.70
569 Amplitude SAS [France] Duotech Amplitude SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 1.00 4.40
570 Amplitude SAS [France] Amplitude Sud SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 6.30 15.30
571 Amplitude SAS [France] Amplitude Nord SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 7.30 15.20
572 Amplitude SAS [France] Ortho Sant� (Amplitude Ouest) [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 534.60 43.50
573 Amplitude SAS [France] Amplitude Benelux [Belgium] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 465.90 644.00
574 Amplitude SAS [France] Amplitude Suisse SA [Switzerland] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 47.90 105.50
575 Amplitude SAS [France] Amplitude GmbH [Germany] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 7.30 95.70
576 Amplitude Surgical SAS Amplitude SAS [France] Subsidiary Company Sale of goods or services 0.00 N.A. 1,749.10 0.00 0.00
577 Amplitude Surgical SAS Amplitude SAS [France] Subsidiary Company Interest received 0.00 N.A. 908.70 0.00 0.00
578 Amplitude Surgical SAS SCI Les Tilleuls [France] Subsidiary Company Interest received 0.00 N.A. 39.30 0.00 0.00
579 Amplitude Surgical SAS Amplitude SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 2.40
580 Amplitude Surgical SAS Amplitude SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 35,261.80 38,706.10
581 Amplitude Surgical SAS SCI Les Tilleuls [France] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 2,605.50 2,760.30
582 Amplitude Ile de France [France] Amplitude Sud SAS [France] Subsidiary Company Purchase of goods or services 0.00 N.A. 7.10 0.00 0.00
583 Amplitude Ile de France [France] Duotech Amplitude SAS [France] Subsidiary Company Sale of goods or services 0.00 N.A. 4.60 0.00 0.00
584 Amplitude Ile de France [France] Amplitude Sud SAS [France] Subsidiary Company Sale of goods or services 0.00 N.A. 4.10 0.00 0.00
585 Amplitude Ile de France [France] Amplitude Nord SAS [France] Subsidiary Company Sale of goods or services 0.00 N.A. 3.10 0.00 0.00
586 Amplitude Ile de France [France] Amplitude Sud SAS [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 2.10 9.20
587 Amplitude Ile de France [France] Duotech Amplitude SAS [France] Subsidiary Company Purchase of goods or services 0.00 N.A. 3.10 0.00 0.00
588 Amplitude Ile de France [France] Duotech Amplitude SAS [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 4.00
589 Amplitude Ile de France [France] Duotech Amplitude SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 3.10 2.70
590 Amplitude Ile de France [France] Amplitude Sud SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 2.10 2.80
591 Amplitude Ile de France [France] Amplitude Nord SAS [France] Subsidiary Company Purchase of goods or services 0.00 N.A. 3.80 0.00 0.00
592 Amplitude Ile de France [France] Amplitude Nord SAS [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 4.90
593 Amplitude Ile de France [France] Amplitude Nord SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 2.10 2.00
594 Comfort Click Softech Pvt. Ltd. Comfort Click Limited (UK) Subsidiary Company Sale of goods or services 0.00 N.A. 2,026.90 0.00 0.00
595 Comfort Click Limited (UK) Comfort Click Limited (Ireland) Subsidiary Company Sale of goods or services 0.00 N.A. 183.20 0.00 0.00
596 Comfort Click Limited (UK) Comfort Click Limited (Ireland) Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 N.A. 713.70 0.00 0.00
597 Comfort Click Limited (UK) Comfort Click Limited (Ireland) Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 1,291.00 1,373.40
598 Comfort Click Limited (UK) Comfort Click Softech Pvt. Ltd. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 93.80 303.30
599 Zydus Lifesciences Limited Zydus Foundation Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Corporate Social Responsibility (CSR) Expenses 0.00 N.A. 4,620.00 0.00 0.00
Total value of transaction during the reporting period 13,33,061.70



Text Block

Textual Information(1) Loan Given 6 Month T Bill + 80 BPS
Textual Information(2) Purchase / Subscription of Investments. Opening and closing balance are not given where there was no transaction of Investment during the half year ended March 31, 2026.
Textual Information(3) Purchase / Subscription of Investments.
Textual Information(4) Loan Given 1 Month T Bill + 90 BPS
Textual Information(5) Loan Given 1 Month T Bill + 80 BPS
Textual Information(6) Loan Given 1 Month T Bill + 95 BPS
Textual Information(7) Loan Given 6 Month SONIA + 215 BPS
Textual Information(8) Purchase / Subscription of Investments.
Textual Information(9) Loan Given 6 Month SOFR + 285 BPS
Textual Information(10) Purchase / Subscription of Investments.
Textual Information(11) Loan Given 1 Month T Bill + 120 BPS
Textual Information(12) Loan Given 6 Month T Bill + 85 BPS
Textual Information(13) Loan Given 1 Month T Bill + 120 BPS
Textual Information(14) Loan Given 1 Month T Bill + 85 BPS
Textual Information(15) Loan Given 1 Month T Bill + 120 BPS
Textual Information(16) Loan Given 1 Month T Bill + 90 BPS
Textual Information(17) Loan Given 3 Month SOFR + 50 BPS
Textual Information(18) Loan Given 3 Month SOFR + 50 BPS
Textual Information(19) Loan Given 3 Month SOFR + 50 BPS
Textual Information(20) Loan Given 3 Month SOFR + 50 BPS
Textual Information(21) Loan Given 3 Month SOFR + 50 BPS
Textual Information(22) Loan Given 3 Month SOFR + 50 BPS
Textual Information(23) Loan Given 3 Month SOFR + 50 BPS
Textual Information(24) Purchase / Subscription of Investments.
Textual Information(25) Purchase / Subscription of Investments.
Textual Information(26) Loan Given 6 Month SOFR + 85 BPS
Textual Information(27) Purchase / Subscription of Investments.
Textual Information(28) Purchase / Subscription of Investments.
Textual Information(29) Loan Given 3 Month EURIBOR + 150 BPS